ARGX argenx SE

ARGX argenx SE

Healthcare · Biotechnology

Desk view

Watchingmedium conviction
Basis Logged decision
Updated

Market read

Scan convergence 1 scan as of 2026-08-17 1 neutral converging

POC $842.01 · VWAP $813.35 · +21.4% vs 12m avg buyer

uptrend vol: expandinggaps: overnight-shiftchurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Coverage

2 watchlists

Watchlists @focus@ibb

ARGX Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist ARGX belongs to, members best 30-day change first — ARGX highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@ibb
@focus

Next earnings ARGX reports in 65 days Oct 22

Against street estimates

How ARGX's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 9 quarters · newest report Jul 23 · projection Aug 17

Result
Jul 23 6.197.32+18.2%Beat
May 7 4.925.52+12.1%Beat
Feb 26 6.118.02+31.2%Beat
Oct 30 '25 4.165.18+24.5%Beat
Jul 31 '25 3.023.74+24.0%Beat
May 8 '25 2.312.58+11.7%Beat
Feb 27 '25 1.770.75-57.7%Miss
Oct 31 '24 0.061.39+2120.1%Beat

Recent news

Headlines about ARGX from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 3 days ago · Aug 15

Types